Abstract:Acute pancreatitis (AP) is a common inflammatory disorder of the pancreas that causes severe abdominal pain and multiple organ dysfunction. The annual incidence of AP ranges from 13 to 45 per 100,000 individuals. [ 1 ] Hypertriglyceridemia has become the second most common cause of AP, [ 2 ] and related published studies have revealed that AP caused by hypertriglyceridemia [i.e., hypertriglyceridemia-associated AP (HTG-AP)] is more common than AP caused by other factors. [ 3 , 4 ] The diagnosis of HTG-AP can be made when serum triglyceride (TG) levels are ≥ 11.3 mmol/L (1000 mg/dL) in the presence of AP; it has been recommended that serum TG levels ≥ 5.65 mmol/L (500 mg/dL) accompanied by milky serum can also be considered as a diagnostic criterion. [ 5 ] HTG-AP has a higher morbidity due to complications and poorer outcomes than other types of AP. [ 6 , 7 ] The Atlanta classification defines 3 degrees of severity: Mild acute pancreatitis (MAP), moderately severe acute pancreatitis and severe acute pancreatitis (SAP). SAP is defined by persistent organ failure, that is, organ failure > 48 h. Organ failure often manifests with respiratory, renal, or cardiovascular failure. [ 8 ] Common stratification and prognostic models for AP include the Acute Physiology and Chronic Health Evaluation-II score (APACHE-II), Ranson score and BISAP score, as well as the Glasgow scoring system (GCS). The original Ranson criteria include a scoring system consisting of 11 parameters used to assess the severity of AP, which were initially used to score alcoholic pancreatitis. It includes inflammation indicators, body fluid loss, liver and kidney function indicators, but does not include lipid metabolism indicators. Similarly, other scores are not particularly applied in HTG-AP due to the specific etiology and pathophysiological process. On the one hand, these system scores are inaccurate in predicting the severity of HTG-AP and prognosis. On the other hand, they cannot be displayed graphically. [ 9 , 10 ] Herein, more attention was paid to the Ranson score as it is the most widely used and has maintained its clinical effectiveness for years. In clinical practice, the data demonstrated that the imaging findings of the pancreas on an early computerized tomography (CT) scan could only reflect the severity at the time of admission, but could not predict the prognosis of HTG-AP. Therefore, more parameters from CT scans are required to anticipate the severity of HTG-AP in future therapy. In recent years, studies have found that abnormal lipid metabolism is the main cause of HTG-AP. [ 11–14 ] However, in addition to lipid profiles, there is a lack of examinations to classify the abnormality of lipid metabolism vividly. The present study promotes a multidimensional judgment combined with laboratory analyses and imageology for the diagnosis and prognosis of metabolic diseases; this may be helpful for evaluating the prognosis of HTG-AP and may enable early intervention for further blocking the development of MAP to severe pancreatitis. Liver fatty infiltration on a CT scan was selected and combined with hematological indicators to grade the severity of HTG-AP at an early stage. This novel established system scoring can help doctors to assess and treat SAP at an early stage, as well as to reduce the incidence of SAP.

Predicting the Incidence of Portosplenomesenteric Vein Thrombosis in Patients with Acute Pancreatitis Using Classification and Regression Tree Algorithm

Prediction of the Severity of Acute Pancreatitis Using Machine Learning Models.

A Diagnostic Prediction Model of Acute Symptomatic Portal Vein Thrombosis.

Predicting Risk for Portal Vein Thrombosis in Acute Pancreatitis Patients: A Comparison of Radical Basis Function Artificial Neural Network and Logistic Regression Models

Diagnostic Prediction of portal vein thrombosis in chronic cirrhosis patients using data-driven precision medicine model

A nomogram model to predict the portal vein thrombosis risk after surgery in patients with pancreatic cancer

Analysis of risk factors for acute pancreatitis complicated with pancreatic sinistral portal hypertension and construction of predictive model

Comparison of MPL-ANN and PLS-DA models for predicting the severity of patients with acute pancreatitis: An exploratory study

Development and validation of a prediction model for deep vein thrombosis in older non-mild acute pancreatitis patients

Investigating the relationship between the portal venous systemic thrombosis in early acute pancreatitis and the severity and classification of acute pancreatitis using MRI

Portosplenomesenteric vein thrombosis in patients with early-stage severe acute pancreatitis

Predicting the Clinical Manifestations in Necrotizing Acute Pancreatitis Patients with Splanchnic Vein Thrombosis.

Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers

Development and validation of a risk prediction model and scoring system for post-endoscopic retrograde cholangiopancreatography pancreatitis

Early Prediction of Severe Acute Pancreatitis Using Machine Learning

Machine learning predicts portal vein thrombosis after splenectomy in patients with portal hypertension: Comparative analysis of three practical models

Prediction of severe hypertriglyceridemia-associated acute pancreatitis using a nomogram based on CT findings and blood biomarkers

Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients

Preoperative prediction of peripancreatic vein invasion by pancreatic head cancer

Guiding post-pancreaticoduodenectomy interventions for pancreatic cancer patients utilizing decision tree models

A Risk Prediction Model for Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis After Stent Insertion for Malignant Biliary Obstruction: Development and Validation